TipRanks
TipRanksTop Financial ExpertsInsidersBarry Greene

Barry Greene Insider Profile

11 Followers
Barry Greene, Director at Dyne Therapeutics, holds ― shares in Dyne Therapeutics (Ticker: DYN), holds 16.41K shares in Karyopharm Therapeutics (Ticker: KPTI), holds 0.00 shares in SAGE Therapeutics (Ticker: SAGE). Most recently, Barry Greene ― shares of Dyne Therapeutics on ― for an estimated value of ―.
See the Hottest Stocks Based on Insider Trading >
tipranks
Barry Greene

Barry Greene
Dyne Therapeutics (DYN)
Director

Ranked #98,014 out of 109,193 Corporate Insiders

Profitable Transactions

0%
0 out of 5 Profitable Transactions

Average Return

-38.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$19M
99.86%
0.14%
0.00%
A breakdown of Barry Greene's holdings
See the Top Stocks by Insiders

Insider Roles

Alnylam Pharma
(ALNY)
President
Karyopharm Therapeutics
(KPTI)
Director
Dyne Therapeutics
(DYN)
Director
Roles that Barry Greene holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
SAGE Therapeutics
(SAGE)
Rating:Informative Buy
Date:Aug 09, 2021 - Aug 09, 2022
Return:-2.80%
The most profitable trade made by Barry Greene
See the Latest Stocks Traded by Insiders

Barry Greene's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
DYN
Dyne Therapeutics
―
Director
―
―
SAGE
SAGE Therapeutics
Jul 31, 2025
―
Uninformative Sell
―
$0.00
ALNY
Alnylam Pharma
Sep 11, 2020
President
Uninformative Buy
859.24K
$18.81M
KPTI
Karyopharm Therapeutics
May 26, 2026
Director
Uninformative Buy
―
$26.59K
ACORQ
Acorda Therapeutics
May 23, 2018
―
Uninformative Buy
25.66K
$16.55
RGLS
Regulus
Oct 11, 2012
―
Uninformative Buy
―
$50.19M
List of latest transactions for each holding click on a transaction to see Barry Greene's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Barry Greene insider profile FAQ

What is the percentage of profitable transactions made by Barry Greene?
The percentage of profitable transactions made by Barry Greene is 0%.
    What is the average return per transaction made by Barry Greene?
    The average return per transaction made by Barry Greene is -38.10%.
      What stocks does Barry Greene hold?
      Barry Greene holds: DYN, SAGE, ALNY, KPTI, ACORQ, RGLS stocks.
        What was Barry Greene’s latest transaction?
        Barry Greene latest transaction was an Uninformative Buy of ―.
          What was Barry Greene's most profitable transaction?
          Barry Greene’s most profitable transaction was an Informative Buy of SAGE stock on August 9, 2021. The return on the trade was -2.80%.
            What is Barry Greene's role in Dyne Therapeutics?
            Barry Greene's role in Dyne Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.